Abstract
Calcific uremic arteriopathy (CUA) is a rare complication of uremia. Its pathogenesis is not known, and there is no well-defined treatment for it. In this report we describe CUA in a patient with end-stage renal failure who had undergone hemodialysis (HD) for 12 years. The patient developed end-stage renal failure 12 years prior to this report because of chronic glomerulonephritis, and was managed by HD. He had a renal transplant soon after initiation of HD, but this graft failed within a month because of acute rejection, and HD was resumed. He became hepatitis C positive 2 years later, and tests showed the development of impaired liver function. A year prior to this report, the patient developed tubercular ascites and responded well to antituberculous drugs. Six months prior to this report he noticed the development of multiple ulcerations in his toes and digits with ischemic pain. These lesions slowly increased in number and size. The patient was managed by strictly controlling phosphorus and by anticoagulation, followed by parathyroidectomy. This led to complete healing of most ischemic lesions and improvement of others. We attribute the CUA in this patient to prolonged hyperphosphatemia and hyperparathyroidism. Control of hyperphosphatemia, parathyroidectomy, local care, and anticoagulation are important therapeutic measures for this rare but life-threatening complication of chronic uremia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.